Wall Street brokerages expect that Encompass Health Corp (NYSE:EHC) will post earnings of $0.83 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for Encompass Health’s earnings. The lowest EPS estimate is $0.82 and the highest is $0.86. Encompass Health posted earnings of $0.71 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 16.9%. The business is expected to announce its next quarterly earnings results after the market closes on Wednesday, July 25th.
On average, analysts expect that Encompass Health will report full year earnings of $3.39 per share for the current financial year, with EPS estimates ranging from $3.36 to $3.45. For the next year, analysts anticipate that the firm will post earnings of $3.65 per share, with EPS estimates ranging from $3.55 to $3.75. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that cover Encompass Health.
Get Encompass Health alerts:Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 26th. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.81 by $0.12. Encompass Health had a net margin of 6.76% and a return on equity of 20.76%. The company had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.03 billion.
A number of research analysts have weighed in on the stock. Craig Hallum lifted their price objective on shares of Encompass Health from $63.00 to $71.00 and gave the company a “buy” rating in a report on Monday, April 30th. Royal Bank of Canada lifted their price objective on shares of Encompass Health to $69.00 and gave the company an “outperform” rating in a report on Monday, April 30th. ValuEngine raised shares of Encompass Health from a “buy” rating to a “strong-buy” rating in a report on Friday, April 27th. Robert W. Baird boosted their target price on shares of Encompass Health from $59.00 to $66.00 and gave the stock an “outperform” rating in a research note on Monday, April 30th. Finally, Credit Suisse Group boosted their target price on shares of Encompass Health from $65.00 to $66.00 and gave the stock an “outperform” rating in a research note on Friday, April 27th. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Encompass Health presently has a consensus rating of “Buy” and an average price target of $67.33.
Encompass Health traded down $0.38, reaching $69.87, on Tuesday, according to MarketBeat. The stock had a trading volume of 419,691 shares, compared to its average volume of 1,190,642. Encompass Health has a 12-month low of $42.21 and a 12-month high of $70.43. The company has a debt-to-equity ratio of 1.77, a quick ratio of 1.24 and a current ratio of 1.24. The stock has a market capitalization of $6.90 billion, a price-to-earnings ratio of 23.29, a PEG ratio of 1.59 and a beta of 0.35.
The business also recently announced a quarterly dividend, which was paid on Monday, July 16th. Stockholders of record on Monday, July 2nd were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, June 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.43%. Encompass Health’s dividend payout ratio is currently 36.23%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Article: What does RSI mean?
Get a free copy of the Zacks research report on Encompass Health (EHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment